We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.92B +$7.69M +74,508 +0.4%
BlackRock
2
BlackRock
New York
$1.91B +$31.1M +301,920 +2%
State Street
3
State Street
Massachusetts
$691M -$4.99M -48,332 -0.8%
BAMCO Inc
4
BAMCO Inc
New York
$636M -$5.71M -55,340 -0.9%
Neuberger Berman Group
5
Neuberger Berman Group
New York
$465M -$9.19M -89,064 -2%
BCM
6
Brown Capital Management
Maryland
$398M -$28.3M -273,900 -7%
OCBV
7
Ownership Capital B.V.
Netherlands
$364M -$21.1M -204,220 -6%
FAM
8
Fred Alger Management
New York
$358M -$55.3M -536,424 -14%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$339M +$9.3M +90,148 +3%
Winslow Capital Management
10
Winslow Capital Management
Minnesota
$318M +$42.6M +412,688 +16%
Select Equity Group
11
Select Equity Group
New York
$302M +$288M +2,793,944 New
DDC
12
DF Dent & Co
Maryland
$297M +$2.09M +20,272 +0.7%
MPI
13
Mairs & Power Inc
Minnesota
$285M +$1.71M +16,588 +0.6%
Ameriprise
14
Ameriprise
Minnesota
$271M +$45.5M +440,596 +21%
JSP
15
Jackson Square Partners
California
$251M -$8.5M -82,344 -3%
Massachusetts Financial Services
16
Massachusetts Financial Services
Massachusetts
$237M -$75.1M -727,440 -25%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$229M +$37M +358,972 +20%
Allspring Global Investments
18
Allspring Global Investments
North Carolina
$219M +$107M +1,040,640 +106%
CIP
19
Champlain Investment Partners
Vermont
$215M +$30.3M +294,020 +17%
ACM
20
Atlanta Capital Management
Georgia
$211M +$1.47M +14,244 +0.7%
Invesco
21
Invesco
Georgia
$208M -$4.11M -39,872 -2%
William Blair Investment Management
22
William Blair Investment Management
Illinois
$206M -$44.4M -430,140 -18%
Wellington Management Group
23
Wellington Management Group
Massachusetts
$198M +$41.9M +406,268 +29%
Northern Trust
24
Northern Trust
Illinois
$191M -$1.16M -11,288 -0.6%
Norges Bank
25
Norges Bank
Norway
$158M -$696K -6,748 -0.5%

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.